RxDoctor Payments Data

Olaya Brewer Gutierrez, MD

Gastroenterology · Baltimore, MDNPI 1629420948

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (54.9%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Boston Scientific at 55.4% of the total. Among gastroenterology clinicians in MD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$59,819in general payments, 2019–2025

Across 104 payments — averaging $575.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$33K
  • Merit Medical Systems Inc$12K
  • Wilson Cook Medical Incorporated$6K
  • Endogastric Solutions, Inc$6K
  • Ovesco Endoscopy USA, Inc.$650
  • Olympus Corporation Of The Americas$640
  • plus $2K from 10 others

What the payments were for

  • Consulting fees$16,52528%
  • Speaking & faculty fees$32,85055%
  • Travel & lodging$5,0909%
  • Food & beverage$5,3539%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$59,819 in reported general payments places this provider in the 90th percentile of 455 gastroenterology providers in Maryland.

See all gastroenterology providers in Maryland

Medicare billing

Part B allowed, 2024
$160,859
Medicare patients
436
Services billed
989

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Famotidine79$1,575
Omeprazole64$1,373
Esomeprazole Magnesium21$1,107
Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg43$842
Rabeprazole Sodium13$801
Pantoprazole Sodium26$476
Ondansetron OdtOndansetron12$173

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Baltimore

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →